Every earnings call for ACCENTMIC — management tone, guidance, KPIs and promise tracking, quarter by quarter.
ACCENTMIC · 3 transcripts · Healthcare · latest Q4 FY26Accent Microcell has 3 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Total Sales ₹350 cr; Manufacturing Sales ₹260 cr; Trading Sales ₹90 cr. Total sales volume for FY26 reached 15,000 metric tons.
Read full transcript & analysisRevenue ₹265 cr; EBITDA Margin 16%. Targeting 15-20% CAGR for the next 3-5 years at the company level.
Read full transcript & analysisRevenue ₹265 cr (+8% YoY); EBITDA Margin 15.5%; PAT ₹33 cr (+10% YoY). Revenue from operations increased by 8% YoY to ₹265 crores in FY25.
Read full transcript & analysis